Saturday 17 October 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024. In the quarter to June 2026, revenue grew 71.2%, EPS fell 32.9%, free cash flow grew 140.5% and total debt rose 187.9%, each against the same quarter a year earlier.

449.74 10.07 −2.19%

Follow MDGL

Alert me

Market cap: $10.6B
P/E: 0.0×
Fwd P/E: −71.3×
Dividend yield: —
F-score: n/a
Altman Z: 10.48
Beneish M: 0.50
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(41.22%)	(42.49%)	(49.35%)	(53.31%)
ROA Full definition →		(23.74%)	(25.05%)	(27.83%)	(28.77%)
ROIC Full definition →		0.00%	0.00%	(297.52%)	(787.33%)
Return on Tangible Assets Full definition →		(30.17%)	(30.77%)	(36.32%)	(38.86%)
Average Days of Receivables Full definition →		55.83	51.21	60.38	54.67
Free Cash Flow per Share Full definition →		(7.36)	(8.65)	(9.39)	(7.08)
Free Cash Flow Full definition →		(165.54)	(193.99)	(272.61)	(206.28)
Capital Expenditures Full definition →		(4.96)	(4.44)	(4.51)	(8.57)
Other line items
Cash ROIC Full definition →		(7.96%)	(10.05%)	(16.02%)	(12.11%)
Accounts Receivable Turnover Full definition →		10.30	10.18	9.10	9.46
Accounts Payable Turnover Full definition →		0.77	1.21	1.53	3.02
Inventory Turnover Full definition →		0.90	1.03	0.94	1.34
Average Days of Payables Full definition →		466.74	317.74	282.77	115.13
Days of Inventory on Hand Full definition →		719.89	486.52	521.21	331.53
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		40.22%	40.54%	40.00%	38.17%
Selling, General and Administrative Expense of Revenue Full definition →		96.55%	84.91%	80.75%	78.43%
Share Based Compensation of Revenue Full definition →		12.15%	10.24%	9.82%	9.46%
Interest Coverage Full definition →		(17.56)	(13.45)	(11.68)	(10.24)
Operating CF/Net income Full definition →		0.56	0.66	0.87	0.61
Depreciation/Fixed assets Full definition →		1.65	4.22	0.83	0.64
Capex/Depreciation Full definition →		(1.03)	(0.70)	(0.67)	(1.16)
Revenue per Share Full definition →		32.94	42.72	39.01	44.05
Operating CF per Share Full definition →		(7.14)	(8.45)	(9.23)	(6.78)
Capex per Share Full definition →		(0.22)	(0.20)	(0.16)	(0.29)
Capex to Sales Full definition →		0.01	0.00	0.00	0.01

Fold the line items

Columns are period end dates

Stockrow Weekly